John M. Amatruda - Concepedia

Author

John M. Amatruda

Also Known As

J Amatruda, J M Amatruda, J. Amatruda, J. M. AMATRUDA, J. M. Amatruda, J.M. Amatruda, JOHN M. AMATRUDA, JOHN M. Amatruda, John Amatruda, John M Amatruda

Publications

6.3K

Citations

H-Index

Concepts

All Affiliations

University of Rochester Merck & Co., Inc., Rahway, NJ, USA (United States)Johns Hopkins University University of Rochester Medical Center Pennington Biomedical Research Center

About

John M. Amatruda is an author at University of Rochester specializing in medicine, physiology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	48	3.1K
2	Health Sciences	27	35	2.3K
3	Public Health	4	4	415
4	Natural Sciences	3	3	52
5	Applied Physiology	1	1	14

John M. Amatruda

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes Tina Vilsbøll, Julio Rosenstock, H Yki-Järvinen, Diabetes Obesity and Metabolism	2009	303
Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes Itamar Raz, Yu Chen, Mei Wu, Current Medical Research and Opinion	2008	259
Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency Juliana C.N. Chan, Russell Scott, Juan Camilo Arjona Ferreira, Diabetes Obesity and Metabolism	2008	238
Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study Thomas Seck, Michael A. Nauck, Sheila Sunga, International Journal of Clinical Practice	2010	202
The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake Carol Addy, Hamish Wright, Koen Van Laere, Cell Metabolism ObesityMetabolic SyndromeCaloric RestrictionEnergy MetabolismEnergy Homeostasis	2008	200
Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults Ngozi Erondu, Ira Gantz, Bret J. Musser, Cell Metabolism ObesityMetabolic SyndromeMeaningful Weight LossPhysiologyObesity Management	2006	181
Dipeptidyl Peptidase-4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP-1 Elizabeth Migoya, Raynald Bergeron, Jutta Miller, Clinical Pharmacology & Therapeutics	2010	175
Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. Jun Ren, Bess A. Marshall, Mike Mueckler, Journal of Clinical Investigation NutritionInsulin SignalingObesityMetabolic SyndromeKinesiology	1995	171
Efficacy and Safety of Intranasal Peptide YY3–36 for Weight Reduction in Obese Adults Ira Gantz, Ngozi Erondu, Madhuja Mallick, The Journal of Clinical Endocrinology & Metabolism	2007	160
Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea Viswanathan Mohan, Wenying Yang, Ho‐Young Son, Diabetes Research and Clinical Practice Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseGlobal HealthDiabetes	2008	158

Page 1